Russell Investments Group, Ltd. Protagonist Therapeutics, Inc Transaction History

Russell Investments Group, Ltd.

  • $66.8 Billion
  • Q3 2024

A detailed history of Russell Investments Group, Ltd. transactions in Protagonist Therapeutics, Inc stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 24 shares of PTGX stock, worth $1,078. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24
Previous 1,216 98.03%
Holding current value
$1,078
Previous $42,000 97.62%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$33.72 - $47.33 $40,194 - $56,417
-1,192 Reduced 98.03%
24 $1,000
Q1 2024

May 08, 2024
BUY
$21.79 - $32.15 $26,496 - $39,094
1,216 New
1,216 $35,000
Q3 2023

Nov 13, 2023
SELL
$16.68 - $23.66 $725,746 - $1.03 Million
-43,510 Reduced 99.97%
12 $0
Q2 2023

Aug 10, 2023
SELL
$18.02 - $29.36 $1.02 Million - $1.66 Million
-56,564 Reduced 56.52%
43,522 $1.2 Million
Q1 2023

May 09, 2023
SELL
$10.78 - $25.38 $1.07 Million - $2.51 Million
-98,883 Reduced 49.7%
100,086 $2.3 Million
Q4 2022

Feb 08, 2023
SELL
$7.36 - $11.17 $234,622 - $356,077
-31,878 Reduced 13.81%
198,969 $2.17 Million
Q3 2022

Nov 04, 2022
SELL
$7.86 - $11.71 $461,499 - $687,552
-58,715 Reduced 20.28%
230,847 $1.94 Million
Q2 2022

Jul 29, 2022
BUY
$7.06 - $25.52 $751,508 - $2.72 Million
106,446 Added 58.13%
289,562 $2.29 Million
Q1 2022

May 05, 2022
BUY
$23.34 - $36.08 $455,760 - $704,534
19,527 Added 11.94%
183,116 $4.34 Million
Q4 2021

Jan 21, 2022
BUY
$17.63 - $37.1 $1.53 Million - $3.21 Million
86,587 Added 112.45%
163,589 $5.59 Million
Q3 2021

Nov 08, 2021
BUY
$12.95 - $49.69 $297,824 - $1.14 Million
22,998 Added 42.59%
77,002 $1.36 Million
Q2 2021

Aug 04, 2021
BUY
$25.57 - $44.88 $83,639 - $146,802
3,271 Added 6.45%
54,004 $2.42 Million
Q1 2021

May 10, 2021
SELL
$19.02 - $31.15 $82,299 - $134,786
-4,327 Reduced 7.86%
50,733 $1.31 Million
Q4 2020

Feb 08, 2021
SELL
$18.49 - $25.13 $948,389 - $1.29 Million
-51,292 Reduced 48.23%
55,060 $1.11 Million
Q3 2020

Nov 09, 2020
SELL
$15.19 - $22.4 $1.15 Million - $1.69 Million
-75,384 Reduced 41.48%
106,352 $2.08 Million
Q2 2020

Aug 05, 2020
BUY
$6.19 - $18.84 $478,462 - $1.46 Million
77,296 Added 74.01%
181,736 $3.21 Million
Q1 2020

May 06, 2020
BUY
$5.4 - $9.22 $307,108 - $524,359
56,872 Added 119.56%
104,440 $736,000
Q4 2019

Jan 29, 2020
SELL
$4.69 - $13.45 $137,262 - $393,641
-29,267 Reduced 38.09%
47,568 $334,000
Q3 2019

Nov 01, 2019
BUY
$9.41 - $16.56 $723,017 - $1.27 Million
76,835 New
76,835 $926,000
Q4 2018

Feb 11, 2019
SELL
$6.3 - $10.44 $37,170 - $61,596
-5,900 Closed
0 $0
Q3 2018

Oct 26, 2018
BUY
$6.82 - $11.26 $40,238 - $66,434
5,900 New
5,900 $61,000

Others Institutions Holding PTGX

# of Institutions
247
Shares Held
56.4M
Call Options Held
76.3K
Put Options Held
114K
View Full List

About Protagonist Therapeutics, Inc

PTGX Quotes by TradingView
  • Ticker PTGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,084,100
  • Market Cap $2.21B
  • Description
  • Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...
More about PTGX
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email